PERSPECTA

News from every angle

← Back to headlines

GRAIL Reaffirms Galleri Sales Growth and Expands Sales Force After NHS Trial

GRAIL has reiterated its guidance for 22%-32% Galleri sales growth by 2026 and plans to expand its sales force following the NHS-Galleri trial.

20 Feb, 09:41 — 20 Feb, 09:41
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

seeking-alpha1d ago

Grail slides as trial misses primary endpoint, fails to show significant stage III-IV cancer reduction

Read full article →

Related Stories

Canadian Communities Offer Incentives to Recruit Family Doctors Amid Shortage

5m ago

Plastic Surgeon Identifies Key Factor in Skin Aging

1h ago

Domestic Abuse Refuges Employ Female Tradespeople to Enhance Survivor Safety

2h ago

Lebanon High School Honors Jayden Bailey After His Death from Cancer

2h ago